Clinical Trials

A Phase 2b, Open-Label, Single Arm, Multi-Center Study to Assess the Efficacy and Safety of BST-236 as a Single Agent in Adults with Newly-Diagnosed Acute Myeloid Leukemia, Not Eligible for Standard Induction Therapy


Study ID
BST002

NCT Number
NCT03435848 (Click on the NCT number for more information about the trial)

Research Study Number
2018-0478

Principle Investigator
Dr. Koprivinikar, Jamie

Phase
II

Sponsor
BioSight Ltd.


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now